Mighty Capital is a Silicon Valley venture capital firm that invests in companies building “products that count:” products that transform lives and create value at scale. What is unique about us is that we co-invest with top VCs at a later stage. We pull this off because we offer value to our portfolio companies that no other venture firm offers:
- The combination of handpicked Silicon Valley investors (past performance: >6X net, realized cash on cash), and
- Access to one of the largest pools of early adopters and product managers in the world (>200,000 product managers and entrepreneurs), which can become new hires, sales leads, partners and more.
As a result, our portfolio companies say that we bring the “best value for the dollar invested.” Mighty Capital is committed to being the most helpful investor partner you will ever have.
SC Moatti is a technology visionary, entrepreneur and investor. She is the founding partner of Mighty Capital, a Silicon Valley venture capital firm, and Products That Count, a global community of product managers, leaders and founders. Previously, she built products that billions of people use at Facebook, Nokia and Electronic Arts. SC has an MBA from Stanford Graduate School of Business and a MS in Electrical Engineering.
Jennifer has over 20 years of experience across a broad range of technologies, with extensive experience in the mobile and security industries. She has held management and executive roles in start-ups and innovation units of large organizations including Price Waterhouse, Nokia, VASCO Data Security and Telefonica. She looks for teams that can execute their go-to-market strategies.
Ron Gentile is an entrepreneur, startup executive and advisor. He’s been responsible for two Top 20 mobile apps and technologies used by billions of users. His expertise includes consumer, mobile, web, digital imaging & video and digital health. He’s raised angel, venture and strategic capital. He began his career at Adobe and earned his PhD in electrical engineering from Purdue University.
Allen is an experienced life science executive and entrepreneur. Most recently he was CEO & Chair of Sony Biotechnology. His domain expertise includes medical devices, therapeutics, in vitro diagnostics, chemistry, analytic instruments and software. A trained neuro-scientist, Allen has held research positions at Howard Hughes Medical Institute and NASA. Dr. Poirson obtained his PhD from Stanford.